L. Rahib, B. D. Smith, R. Aizenberg, A. B. Rosenzweig, J. M. Fleshman et al., Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States, Cancer Res, 2014.

E. Costello, W. Greenhalf, and J. P. Neoptolemos, New biomarkers and targets in pancreatic cancer and their application to treatment, Nat Rev Gastroenterol Hepatol, 2012.

A. Neesse, P. Michl, K. K. Frese, C. Feig, N. Cook et al., Stromal biology and therapy in pancreatic cancer, Gut, 2011.

P. P. Provenzano, C. Cuevas, A. E. Chang, V. K. Goel, V. Hoff et al., Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma, Cancer Cell, 2012.

M. Schnurr, P. Duewell, C. Bauer, S. Rothenfusser, K. Lauber et al., Strategies to relieve immunosuppression in pancreatic cancer, Immunotherapy, 2015.

I. M. Stromnes, T. M. Schmitt, A. Hulbert, J. S. Brockenbrough, H. Nguyen et al., T cells engineered against a native antigen can surmount immunologic and physical barriers to treat pancreatic ductal adenocarcinoma, Cancer Cell, 2015.

D. I. Gabrilovich, S. Ostrand-rosenberg, and V. Bronte, Coordinated regulation of myeloid cells by tumours, Nat Rev Immunol, vol.12, pp.253-68, 2012.

V. Bronte, S. Brandau, S. H. Chen, M. P. Colombo, A. B. Frey et al., Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards, Nat Commun, vol.7, p.12150, 2016.

S. Ostrand-rosenberg and C. Fenselau, Myeloid-derived suppressor cells: immunesuppressive cells that impair antitumor immunity and are sculpted by their environment, J Immunol, vol.200, pp.422-453, 2018.

L. J. Bayne, G. L. Beatty, N. Jhala, C. E. Clark, A. D. Rhim et al., Tumorderived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer, Cancer Cell, 2012.

Y. Pylayeva-gupta, K. E. Lee, C. H. Hajdu, G. Miller, and D. Bar-sagi, Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia, Cancer Cell, 2012.

C. E. Clark, S. R. Hingorani, M. R. Combs, C. Tuveson, D. A. Vonderheide et al., Dynamics of the immune reaction to pancreatic cancer from inception to invasion, Cancer Res, 2007.

I. M. Stromnes, J. S. Brockenbrough, K. Izeradjene, M. A. Carlson, C. Cuevas et al., Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity, Gut, vol.63, pp.1769-81, 2014.

B. L. Mundy-bosse, G. S. Young, T. Bauer, E. Binkley, M. Bloomston et al., Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4+ T cells from patients with GI malignancy, Cancer Immunol Immunother, 2011.

R. F. Gabitass, N. E. Annels, D. D. Stocken, H. A. Pandha, and G. W. Middleton, Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13, Cancer Immunol Immunother, 2011.

M. R. Porembka, J. B. Mitchem, B. A. Belt, C. S. Hsieh, H. M. Lee et al., Pancreatic adenocarcinoma induces bone marrow mobilization of myeloidderived suppressor cells which promote primary tumor growth, Cancer Immunol Immunother, 2012.

K. Oleinika, R. J. Nibbs, G. J. Graham, and A. R. Fraser, Suppression, subversion and escape: the role of regulatory T cells in cancer progression, Clin Exp Immunol, 2013.

H. Nishikawa and S. Sakaguchi, Regulatory T cells in cancer immunotherapy, Curr Opin Immunol, vol.27, pp.1-7, 2014.

F. Finotello and Z. Trajanoski, New strategies for cancer immunotherapy: targeting regulatory T cells, Genome Med, 2017.

X. Wang, M. Lang, T. Zhao, X. Feng, C. Zheng et al., Cancer-FOXP3 directly activated CCL5 to recruit FOXP3(+)Treg cells in pancreatic ductal adenocarcinoma, Oncogene, vol.36, pp.3048-58, 2017.

M. C. Tan, P. S. Goedegebuure, B. A. Belt, B. Flaherty, N. Sankpal et al., Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer, J Immunol, 2009.

M. B. Wachsmann, L. M. Pop, and E. S. Vitetta, Pancreatic ductal adenocarcinoma: a review of immunologic aspects, J Investig Med, 2012.

T. Fujimura, S. Ring, V. Umansky, K. Mahnke, and A. H. Enk, Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas, J Invest Dermatol, vol.132, pp.1239-1285, 2012.

P. Serafini, S. Mgebroff, K. Noonan, and I. Borrello, Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells, Cancer Res, vol.68, pp.5439-5488, 2008.

E. Schlecker, A. Stojanovic, C. Eisen, C. Quack, C. S. Falk et al., Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth, J Immunol, 2012.

S. M. Centuori, M. Trad, C. J. Lacasse, D. Alizadeh, C. B. Larmonier et al., Myeloid-derived suppressor cells from tumor-bearing mice impair TGF?-induced differentiation of CD4 + CD25 + FoxP3 + Tregs from CD4 + CD25-FoxP3-T cells, J Leukoc Biol, vol.92, pp.987-97, 2012.

M. G. Chai, C. Kim-fuchs, E. Angst, and E. K. Sloan, Bioluminescent orthotopic model of pancreatic cancer progression, J Vis Exp, vol.50395

D. Anz, W. Mueller, M. Golic, W. G. Kunz, M. Rapp et al., CD103 is a hallmark of tumor-infiltrating regulatory T cells, Int J Cancer, 2011.

R. B. Holmgaard, D. Zamarin, Y. Li, B. Gasmi, D. H. Munn et al., Tumor-expressed IDO recruits and activates MDSCs in a Treg-dependent manner, Cell Rep, 2015.

A. Amedei, E. Niccolai, and D. Prisco, Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy, Hum Vaccin Immunother, 2014.

P. R. Kunk, T. W. Bauer, C. L. Slingluff, O. E. Rahma, P. Y. Pan et al., Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer, J Immunother Cancer, 2010.

R. Yang, Z. Cai, Y. Zhang, W. H. Yutzy, . Iv et al., CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1 + CD11b + myeloid cells, Cancer Res, vol.66, pp.6807-6822, 2006.